(Q82086160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Geoffrey Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ben Davidson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ryan Henning

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Junbai Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Minshu Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Christina Annunziata

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Thea Hetland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Elise C Kohn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

25 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1543-1553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Natural history of stage IV epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Malignant effusions: from diagnosis to biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Disruption of epithelial cell-matrix interactions induces apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Anoikis: cancer and the homeless cell

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Control of adhesion-dependent cell survival by focal adhesion kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Nuclear signalling by tumour-associated antigen EpCAM

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Cadherin switching in ovarian cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Expression of E-cadherin transcriptional regulators in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Stage IV ovarian cancer: impact of surgical debulking

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Molecular and functional analysis of cadherin-based adherens junctions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

A causal role for E-cadherin in the transition from adenoma to carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

E-Cadherin Suppresses Cellular Transformation by Inhibiting β-Catenin Signaling in an Adhesion-Independent Manner

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.26449

1 reference

7 January 2021

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Tumor microenvironment: what can effusions teach us?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

E-cadherin expression in human epithelial ovarian cancer and normal ovary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Integrin and cadherin synergy regulates contact inhibition of migration and motile activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Cell-cell contacts prevent anoikis in primary human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26449

7 January 2021

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22009736

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/CNCR.26449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009736%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference